当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Preclinical antibiotic pipeline gets a pick-me-up
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-10-30 , DOI: 10.1038/nrd.2017.213 Asher Mullard
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-10-30 , DOI: 10.1038/nrd.2017.213 Asher Mullard
Preclinical antibiotic pipeline gets a pick-me-up , isJats=true)
中文翻译:
临床前抗生素研发备受关注
临床前抗生素研发备受关注 ,isJats = true)
更新日期:2017-11-10
Preclinical antibiotic pipeline gets a pick-me-up, Published online: 30 October 2017; doi:10.1038/nrd.2017.213
NatureArticleSnippet(type=short-summary, markup=CARB-X, a public–private partnership aimed at bolstering the antibiotic pipeline, funded a diverse set of 17 early-stage drug development projects in its first year.
中文翻译:
临床前抗生素研发备受关注
临床前抗生素研发备受关注
临床前抗生素研发备受关注,在线发布:2017年10月30日;doi:10.1038 / nrd.2017.213
NatureArticleSnippet(type = short-summary,markup =CARB-X是旨在加强抗生素研发的公私合作伙伴关系,在成立的第一年就资助了17个早期药物开发项目。